William Ackman may now have enough votes to call a special Allergan, Inc. (NYSE:AGN) shareholder meeting in December, he said in a statement released Friday. It might now matter, says Allergan, as they are planning on holding a special shareholder meeting in December anyway.
Allergan defending itself from Ackman and Valeant
The game of tit for tat, that is the Allergan, Inc. (NYSE:AGN) fight to stave off acquisition by Ackman and Valeant Pharmaceuticals Intl Inc (NYSE:VRX), could result in some finality one way or another, before the end of the year. On Friday...
This content is exclusively for paying members of Hedge Fund Alpha
Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha
Don’t have an account?
Subscribe now and get 7 days free!
This article is only available for Premium Members
Subscribe today and get :
Insider Strategies and Letters to Shareholders from the Top Hedge Funds
Exclusive Access to coverage of Private, Closed-Door Investor Conferences
Hedge Fund Manager Research Currently Producing 21% – 40% Returns Annually
Don’t have an account?
Subscribe now and get 7 days free!